Bendazac
|
|
|
- CAS-Nr.
- 20187-55-7
- Bezeichnung:
- Bendazac
- Englisch Name:
- Bendazac
- Synonyma:
- Versus;AF 983;BENDAZAC;Bindazac;Zildasac;Dogalina;Zildazac;AKOS 90683;Bendazac >Bendazac,97%
- CBNumber:
- CB4222435
- Summenformel:
- C16H14N2O3
- Molgewicht:
- 282.29
- MOL-Datei:
- 20187-55-7.mol
|
Bendazac Eigenschaften
- Schmelzpunkt:
- 161-163°C
- Siedepunkt:
- 424.91°C (rough estimate)
- Dichte
- 1.1658 (rough estimate)
- Brechungsindex
- 1.6240 (estimate)
- storage temp.
- Sealed in dry,Room Temperature
- Löslichkeit
- DMSO (Slightly), Methanol (Slightly, Heated)
- Aggregatzustand
- Solid
- pka
- 2.89±0.10(Predicted)
- Farbe
- Crystals from ethanol
- maximale Wellenlänge (λmax)
- 306nm(lit.)
- Merck
- 14,1035
- InChIKey
- BYFMCKSPFYVMOU-UHFFFAOYSA-N
- CAS Datenbank
- 20187-55-7(CAS DataBase Reference)
Sicherheit
- Risiko- und Sicherheitserklärung
- Gefahreninformationscode (GHS)
| RTECS-Nr. |
AF5085000 |
|
|
| HS Code |
2933998090 |
|
|
| Toxizität |
LD50 in mice, rats (mg/kg): 380, 304 i.v.; 355, 388 i.p.; 440, 910 s.c.; 1105, ~1200 orally (Rx Bulletin) |
|
|
| Bildanzeige (GHS) |
|
| Alarmwort |
Warnung |
| Gefahrenhinweise |
| Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
| H302 |
Gesundheitsschädlich bei Verschlucken. |
Akute Toxizität oral |
Kategorie 4 |
Warnung |
![GHS hazard pictograms]() src="/GHS07.jpg" width="20" height="20" /> |
P264, P270, P301+P312, P330, P501 |
|
| Sicherheit |
| P264 |
Nach Gebrauch gründlich waschen. |
| P264 |
Nach Gebrauch gründlich waschen. |
| P270 |
Bei Gebrauch nicht essen, trinken oder rauchen. |
| P501 |
Inhalt/Behälter ... (Entsorgungsvorschriften vom Hersteller anzugeben) zuführen. |
|
Bendazac Chemische Eigenschaften,Einsatz,Produktion Methoden
Chemische Eigenschaften
White Solid
Verwenden
Bendazac is a non-steroidal anti-inflammatory drug (NSAID). Bendazac is often used for joint and muscular pain. Bendazac has potential as an anti-denaturant drug for cataract and other condensation di
seases as it protects proteins from denaturation induced by different agents.
Definition
ChEBI: A monocarboxylic acid that is glycolic acid in which the hydrogen attached to the 2-hydroxy group is replaced by a 1-benzyl-1H-indazol-3-yl group. Although it has anti-inflammatory, antinecrotic, choleretic and antilipidaemic properties
nd has been used for the treatment of various inflammatory skin disorders, its principal effect is to inhibit the denaturation of proteins. Its lysine salt is used in the management of cataracts.
Sicherheitsprofil
Poison by intravenous andintraperitoneal routes. Moderately toxic by ingestion andsubcutaneous routes. When heated to decomposition itemits toxic fumes of NOx.
Bendazac Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Bendazac Anbieter Lieferant Produzent Hersteller Vertrieb Händler.
Global( 197)Lieferanten
20187-55-7(Bendazac)Verwandte Suche:
- BENDAZAC
- BENDAZAC ACID
- AKOS 90683
- [[1-(phenylmethyl)-1h-indazol-3-yl]oxy]acetic acid
- 2-(1-BENZYL-1H-INDAZOL-3-YLOXY)ACETIC ACID
- (1-BENZYL-1H-INDAZOL-3-YLOXY)-ACETIC ACID
- [[Benzyl-[1H]-indazol-3-yl] oxy] acetic acid
- BENDAZAC AND ITS SODIUM SALT
- bendazolic acid
- Bindazac
- Versus
- Zildasac
- 1-Benzylindazole-3-oxyacetic Acid
- AF 983
- Dogalina
- Zildazac
- 2-[[1-(phenylmethyl)-3-indazolyl]oxy]acetic acid
- Bendazac >
- Bendazac,97%
- Acetic acid, 2-[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]-
- 1-Benzyl-3-[1-(carboxy)methoxy]indazole
- [(1-Benzyl-3-indazolyl)oxy]acetic Acid
- Bendazac USP/EP/BP
- 20187-55-7
- pharmacetical
- API
- bc0001
